M&A
argenx to Buy Unnatural Products for Up to $1.15 Billion
argenx SE agreed to buy Unnatural Products Inc., a Santa Cruz, Calif., biotech that designs macrocyclic peptides, for $550 million in cash upfront and…
Archive
National Deal News from the HERE CITY Network
Archive
argenx SE agreed to buy Unnatural Products Inc., a Santa Cruz, Calif., biotech that designs macrocyclic peptides, for $550 million in cash upfront and…